These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27965488)

  • 1. Rebamipide to Manage Stomatopyrosis in Oral Submucous Fibrosis.
    Baptist J; Shakya S; Ongole R
    J Contemp Dent Pract; 2016 Dec; 17(12):1009-1012. PubMed ID: 27965488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis.
    Shetty P; Shenai P; Chatra L; Rao PK
    Indian J Dent Res; 2013; 24(3):347-50. PubMed ID: 24025883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study.
    Raizada MK; Sable DM; Chowdhery A; Chavan MS; Rajpurohit LS
    J Oral Pathol Med; 2017 Jul; 46(6):439-442. PubMed ID: 28027413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
    Vedeswari CP; Jayachandran S; Ganesan S
    Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lycopene in the management of oral submucous fibrosis.
    Kumar A; Bagewadi A; Keluskar V; Singh M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):207-13. PubMed ID: 17234537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis.
    Alora Veedu R; Balan A; Sankar S P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):588-593.e1. PubMed ID: 26337213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of betamethasone, hyaluronidase and its combination on mouth opening, burning sensation and QOL in patients with OSF.
    Saalim M; Sansare K; Ali IK; Sonawane H; Singla N; Vanga K; Kapoor R; Karjodkar FR
    J Oral Biol Craniofac Res; 2020; 10(4):492-497. PubMed ID: 32904126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Of Efficacy Of Steroids Alone And Combination Of Steroids With Hyaluronidase On Mouth Opening In Oral Submucous Fibrosis Patients.
    Liaqat S; Ullah A; Waqas MA; Pervez N; Din SU; Ara N
    J Ayub Med Coll Abbottabad; 2022; 34(4):812-816. PubMed ID: 36566405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis.
    Jiang XW; Zhang Y; Yang SK; Zhang H; Lu K; Sun GL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):339-44. PubMed ID: 23260769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis.
    Tilakaratne WM; Ekanayaka RP; Herath M; Jayasinghe RD; Sitheeque M; Amarasinghe H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):224-31. PubMed ID: 27422421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis - a clinical study.
    Anuradha A; Patil B; Asha VR
    J Oral Pathol Med; 2017 Jan; 46(1):50-55. PubMed ID: 27314762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
    Bhadage CJ; Umarji HR; Shah K; Välimaa H
    Clin Oral Investig; 2013 Jun; 17(5):1375-82. PubMed ID: 22893038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort.
    Jiang X; Zhang Y; Li F; Zhu Y; Chen Y; Yang S; Sun G
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1540-6. PubMed ID: 26165773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials.
    Guo J; Xie H; Mao S; Liang M; Wu H
    J Oral Pathol Med; 2020 Apr; 49(4):311-319. PubMed ID: 32145110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis.
    Cox S; Zoellner H
    J Oral Pathol Med; 2009 Feb; 38(2):220-6. PubMed ID: 18673417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan.
    Goel S; Ahmed J
    J Cancer Res Ther; 2015; 11(1):113-8. PubMed ID: 25879347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis.
    Haque MF; Meghji S; Nazir R; Harris M
    J Oral Pathol Med; 2001 Jan; 30(1):12-21. PubMed ID: 11140895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Curcumin in Combination with Intralesional Dexamethasone with Hyaluronidase in the Treatment of Oral Submucous Fibrosis: A Randomized Controlled Trial.
    Adhikari S; Rimal J; Maharjan IK; Shrestha A
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3125-3132. PubMed ID: 36172675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Clinical Features with Candidal Carriage in Oral Submucous Fibrosis Patients: A Case-control Study.
    Redhu A; Suman B; Banu A
    Contemp Clin Dent; 2021; 12(4):359-367. PubMed ID: 35068834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Nepalese Oral Health Impact Profile14 and Assessment of Its Impact in Patients with Oral Submucous Fibrosis in Nepal.
    Rimal J; Shrestha A
    J Nepal Health Res Counc; 2015; 13(29):43-9. PubMed ID: 26411712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.